Literature DB >> 6192956

Characteristics of suppressor factors generated from human mononuclear cells using concanavalin A and C-reactive protein.

A G Wangel, S Kontiainen.   

Abstract

Lymphocytes from normal human donors were cultured in Marbrook flasks in the presence of C-reactive protein (CRP), concanavalin A (Con A) or serum amyloid A protein low molecular weight component (SAAL) and the culture supernatants were tested for their ability to suppress the pokeweed mitogen (PWM) driven response of normal human lymphocytes. The supernatants from CRP and Con A stimulated lymphocytes, when added to cultures at initiation at a final concentration of 5%, suppressed the plaque forming cell (PFC) response in the three major immunoglobulin (Ig) classes. The suppressive effect could be removed by absorption of the culture supernatants with lentil lectin and with antisera to antigen specific helper and suppressor factors and could be recovered in the eluate. The results indicate that CRP stimulated cells exert their suppressive effect through a soluble mediator(s) which is similar to Con A generated suppressor factor(s) in respect to its time of action, its effect on the Ig classes M, G and A, its lack of cytoxicity and some structural aspects.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6192956      PMCID: PMC1535698     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

Review 1.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

2.  Structural characteristics of antigen-specific suppressor factors: definition of 'constant' region and 'variable' region determinants.

Authors:  S Kontiainen; M Feldmann
Journal:  Thymus       Date:  1979-09

3.  Mode of action of a soluble immune response suppressor (SIRS) produced by concanavalin a-activated spleen cells.

Authors:  T Tadakuma; C W Pierce
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  Induction of human antigen-specific suppressor factors in vitro.

Authors:  S Kontiainen; J N Woody; A Rees; M Feldmann
Journal:  Clin Exp Immunol       Date:  1981-03       Impact factor: 4.330

5.  Role of polyclonal activation in specific immune responses. Relevance for findings of antibody activity in various diseases.

Authors:  E Möller; H Ström; S Al-Balaghi
Journal:  Scand J Immunol       Date:  1980       Impact factor: 3.487

6.  Soluble suppressor factor produced by pokeweek mitogen-stimulated human peripheral blood leukocytes.

Authors:  F Hofman; C A Spina; N Rand; J L Fahey
Journal:  Cell Immunol       Date:  1980-09-15       Impact factor: 4.868

7.  Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. I. Characterization of a soluble suppressor T cell proliferation.

Authors:  W C Greene; T A Fleisher; T A Waldmann
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

8.  Soluble suppressor supernatants elaborated by concanavalin A-activated human mononuclear cells. II. Characterization of a soluble suppressor of B cell immunoglobulin production.

Authors:  T A Fleisher; W C Greene; R M Blaese; T A Waldmann
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

9.  Heterogeneity of human serum amyloid A proteins.

Authors:  L L Bausserman; P N Herbert; K P McAdam
Journal:  J Exp Med       Date:  1980-09-01       Impact factor: 14.307

10.  Interferon as a mediator of human lymphocyte suppression.

Authors:  A S Kadish; F A Tansey; G S Yu; A T Doyle; B R Bloom
Journal:  J Exp Med       Date:  1980-03-01       Impact factor: 14.307

View more
  1 in total

1.  Effects of a human urinary mitogen on subpopulations of peripheral blood mononuclear leukocytes.

Authors:  A G Wangel; K Kayhko; S Reitamo; I Jokinen
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.